Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
批准号:
10456820
负责人:
CAROLE A OSKERITZIAN
金额:
$10.36万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-06-30
关键词:
AddressAgeAmericanApcMin/+ miceAppearanceAzoxymethaneBiologicalBlood VesselsBrightfield MicroscopyCancer ControlCarcinogensCell physiologyCellsCellular biologyClinicClinicalColonColonic PolypsColonoscopyColorectal CancerComputer AssistedComputer softwareDNA analysisDataData AnalysesDescriptorDetectionDevelopmentDiffusion Magnetic Resonance ImagingDiseaseDistalDistantDoctor of MedicineEarly DiagnosisEndoscopyEnsureEquipmentEventExcisionFDA approvedFamily PracticeFecesFlexible fiberoptic sigmoidoscopyGenetic ModelsGoldHealthHomeostasisHumanHuman ResourcesImageImage AnalysisImmuneInterventionIntestinal PolyposisIntestinesLaboratoriesLesionLow incomeMalignant NeoplasmsMaster of Public HealthMeasuresMedicalMethodsMicroscopyModalityModelingMorbidity - disease rateMorphologyMusPatientsPerformancePhysiciansPilot ProjectsPolypsPopulationPre-Clinical ModelPrecancerous PolypPreventionPreventive MedicinePrimary Health CareProceduresProcessRetrievalSamplingScheduleSentinelSlideSpecificitySpecimenStainsStandardizationSwabTechnologyTestingTissuesTrainingValidationWild Type Mouseadenomaadherence ratebasecancer geneticscancer preventioncarcinogenesisclinical practicecolorectal cancer preventioncolorectal cancer screeningcomplex datacomputer aided detectioncomputer data analysiscomputerizedcostcost effectivedesigndextran sulfate sodium induced colitisdiagnostic valuedigitalearly onsetearly onset colorectal cancerequipment traininghuman tissueimaging modalityimprovedinnovationintestinal epitheliummast cellmedical schoolsminimally invasivemortalitymouse modelneoplasticpre-clinicalpreclinical studypremalignantpreservationpreventprimary care settingprismaprocedure costprofessorprogramsquantitative imagingrectalsample collectionscreeningtumor progressionuptakevalidation studies
中文摘要
摘要
筛查仍然是结直肠癌(CRC)控制和预防的关键干预措施,因为检测和
切除癌前病变可以防止进展为癌症。结肠镜检查--结直肠癌的黄金标准
筛查是一种侵入性且费用高昂的程序,导致一般人群和低收入人群的依从性较低。
筛查人群,包括低收入和早发年轻患者。粪便筛查方法也包括
合规率较低。负担得起的微创方法迫切需要解决
筛查率低,通过早期发现预防结直肠癌。我们建议探索场的概念
结直肠癌的影响或同时发生结肠癌前息肉远端细微改变
一种创新的方式,开发一种新的结直肠癌筛查模式。肥大细胞(MC)是先天免疫细胞
位于接近肠上皮和血管的动态平衡,其积累是一种
小鼠肠道息肉病和侵袭性肠道病变的基本特征。我们假设MC
可能在癌前病变时在结肠腔内脱落,但在正常健康病例中不会,因此
可与其他细胞一起通过直肠拭子获取。结合我们在量化方面的双重专业知识
成像和肥大细胞(MC)生物学,我们推测拭子采集的细胞可以在显微镜下分析。
采用明视场显微镜和图像分析软件对切片进行处理和MC染色。我们的
使用两种结直肠癌临床前模型的初步结果,即遗传ApcMin/+小鼠模型和
偶氮甲烷/葡聚糖硫酸钠诱导的结肠炎导致结直肠癌,提示拭子MC在
携带息肉,但不在健康的无息肉、发炎的息肉、癌症或野生型小鼠中携带。为了确保
标准化样本分析,我们建议开发一种用于棉签MC检测的计算成像方法
通过集成MC-受限的形态描述符。进一步的生物和技术验证将是
已执行。如果得到证实,我们的工作假设将在人体先导研究中得到验证。
英文摘要
SUMMARY
Screening remains the key intervention for colorectal cancer (CRC) control and prevention as detection and
removal of premalignant lesions can prevent progression to cancer. Colonoscopy, the gold standard for CRC
screening, is an invasive and costly procedure resulting in low compliance in both the general and the under-
screened populations, including low-income and early-onset young patients. Feces-screening methods also
suffer low compliance rates. Affordable and minimally invasive approaches are urgently warranted to address
low screening rates and prevent CRC through early detection. We are proposing to explore the concept of field
effect in CRC or simultaneous occurrence of subtle alterations distal from precancerous polyps in the colon, in
an innovative way, to develop a new screening modality for CRC. Mast cells (MC) are innate immune cells
located close to the intestinal epithelium and blood vessels at homeostasis, whose accumulation is an
essential feature of intestinal polyposis in mice and of invasive intestinal lesions. We hypothesized that MC
might slough off in the colonic lumen upon precancerous transformation, but not in normal healthy cases, thus
being accessible by rectal swabbing, together with other cells. Combining our dual expertise in quantitative
imaging and mast cell (MC) biology, we surmise that swab-collected cells might be analyzed on microscopy
slides after processing and staining for MC using bright-field microscopy and image analysis software. Our
preliminary results using two preclinical models of CRC, the genetic ApcMin/+ mouse model and the
azoxymethane/dextran sulfate sodium-induced colitis leading to CRC, indicate the presence of swab MC in
polyp carrying but not in healthy polyp-free, inflamed polyp-free, cancer-free or wild type mice. To ensure
standardized sample analysis, we propose to develop a computational imaging method for swab MC detection
by integrating MC-restricted morphometric descriptors. Further biological and technical validations will be
performed. If confirm, our working hypothesis will be tested in a human pilot study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity
-
批准号:10650620
-
项目类别:
-
资助金额:$20.9万
-
财政年份:2023
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
-
批准号:10044350
-
项目类别:
-
资助金额:$20.9万
-
财政年份:2020
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
-
批准号:10174880
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2020
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
MicroRNAs in atopic dermatitis pathogenesis: a role for mast cell and sphingosine-1-phosphate?
-
批准号:9035633
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2016
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
48th Annual South Eastern Regional Lipid Conference (SERLC) Funding Support
-
批准号:8651999
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2013
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8295787
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8730283
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8681300
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8859955
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7147486
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7628066
-
项目类别:
-
资助金额:$10.69万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7446651
-
项目类别:
-
资助金额:$10.44万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7257108
-
项目类别:
-
资助金额:$10.2万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7873014
-
项目类别:
-
资助金额:$10.94万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: